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Previous metabolic studies have demonstrated that leishmania parasites are
able to synthesise proline from glutamic acid and threonine from aspartic
acid. The first committed step in both biosynthetic pathways involves an
amino acid kinase, either a glutamate 5-kinase (G5K; EC 2.7.2.11) or an
aspartokinase (EC 2.7.2.4). Bioinformatic analysis of multiple leishmania
genomes identifies a single amino acid-kinase gene (LdBPK 262740.1) vari-
ously annotated as either a putative glutamate or aspartate kinase. To
establish the catalytic function of this Leishmania donovani gene product,
we have determined the physical and kinetic properties of the recombinant
enzyme purified from Escherichia coli. The findings indicate that the
enzyme is a bona fide G5K with no activity as an aspartokinase. Tetra-
meric G5K displays kinetic behaviour similar to its bacterial orthologues
and is allosterically regulated by proline, the end product of the pathway.
The structure-activity relationships of proline analogues as inhibitors are
broadly similar to the bacterial enzyme. However, unlike G5K from
E. coli, leishmania G5K lacks a C-terminal PUA (pseudouridine synthase
and archaeosine transglycosylase) domain and does not undergo higher
oligomerisation in the presence of proline. Gene replacement studies are
suggestive, but not conclusive that G5K is essential.
Enzymes
Glutamate 5-kinase (EC 2.7.2.11); aspartokinase (EC 2.7.2.4).
Introduction
Leishmania parasites are the causative agents of vis-
ceral, cutaneous and mucocutaneous leishmaniasis. The
life-threatening visceral form is responsible for 30 000
to 50 000 deaths per annum and the incidence of the
disfiguring cutaneous form is estimated at 700 000 to
1 300 000 new cases per annum (https://www.dndi.org/
diseases-projects/leishmaniasis/). Treatment options are
limited: there are no efficacious vaccines and currently
available drugs are expensive, difficult to administer
and toxic [1–3]. The disease is transmitted between
mammalian hosts by the bite of a female sand fly.
During their life cycle, the parasites undergo remark-
able morphological and biochemical changes, ranging
from motile flagellated promastigote forms living in the
alkaline midgut of the sand-fly vector to sessile amastig-
otes growing in the acidic parasitophorous vacuole of
the host macrophage [4]. Not only do leishmania have
to adapt to environmental changes in pH, temperature
and osmotic tension but also to changes in nutrient
availability [5]. In addition to intermittent blood feeds,
the female sand fly also feeds on sugars (mainly
sucrose) either from aphid honeydew or from plants.
Abbreviations
DDR, double drug-resistant line; G5K, glutamate 5-kinase; P5CS, D1–pyrroline-5-carboxylate synthase; PUA domain, pseudouridine synthase
and archaeosine transglycosylase domain; RCWT, wild-type leishmania-overexpressing G5K; ROS, reactive oxygen species; SDR, single drug-
resistant line.
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Thus, leishmania parasites live in a sugar- and amino
acid-rich environment in the insect midgut and prefer-
entially use simple sugars as a source of energy. Under
glucose-limiting conditions, leishmania promastigotes
can also use proline as an energy source [6,7]. Some
bloodsucking insects utilise abundant proline in their
haemolymph as an energy source for flight [8–10] where
proline concentrations can be as high as 60 mM; how-
ever, nothing is known about proline levels in the case
of sand flies. In contrast to the promastigote, leishma-
nia amastigotes live in a glucose-poor environment and
utilise fatty acids for energy production and amino
acids for gluconeogenesis [5,11–13].
Metabolic labelling studies with either [14C] or [13C]
glucose indicate that label can be incorporated into gly-
cine, serine, proline, or threonine in amino acid-deficient
medium [6,14]. [U13C] Aspartate is also readily incorpo-
rated into threonine suggesting the presence of the beta-
aspartate pathway to threonine [14]. Glutamate and
aspartate are of interest as the first committed step in
the respective biosynthetic pathways involves an amino
acid kinase, either glutamate 5-kinase (G5K, EC 2.7.2.
11) for proline synthesis, or aspartokinase (EC 2.7.2.4)
for threonine synthesis (Fig. 1). Both of these pathways
are absent in the related parasite Trypanosoma brucei
where threonine constitutes a major source of acetate
for lipid biosynthesis [15–17] and proline is a major
energy source in insect procyclic forms [18–20].
Although bioinformatic analyses of leishmania genomes
have identified suitable candidate genes for all of the
remaining pathway steps in the biosynthesis of proline
and threonine [21], only one putative amino acid kinase
can be identified (e.g. LinJ.26.2740, LmJF.26.2710, and
LdBPK_262740.1). These genes are annotated as puta-
tive G5Ks in GeneDB, but their enzymatic function has
not been characterised. In addition, they have also been
proposed as possible aspartokinases [14,22]. The aim of
this study was to characterise the putative G5K from
Leishmania donovani and assess its possible role in pro-
line and/or threonine biosynthesis.
Results
Sequence analysis of G5Ks
The construction of phylogenetic trees spanning both
higher eukaryotes to lower prokaryotes (Fig. 2) was
built based on their amino sequence and evolutionary
distances were calculated by Poisson correction method
within MEGA7 programme. Leishmania G5Ks (e.g.
LmjF26.2710, LinJ.26.2740, and LdBPK_262740.1) are
located on a clade closer to bacterial and lower eukary-
otes compared to higher eukaryotes. A comparison of
G5K sequences from Escherichia coli, human and
L. donovani (Fig. 3) illustrates some shared homology
in relation to residues interacting with nucleotides, glu-
tamate as well as putative binding motifs for ATP, the
conserved G5K domain and leucine zipper. Of note,
only E. coli contains the C-terminal PUA (pseu-
douridine synthase and archaeosine transglycosylase)
domain, which is present in some bacteria but absent in
the Leishmania equivalent. The PUA domain is poten-
tially involved in RNA binding but its exact function is
still unknown [8,9]. The situation is different in humans
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Fig. 1. Proline and threonine biosynthetic pathways from glutamate and aspartate. Leishmania is predicted to synthesise proline from
glutamate by the same pathway found in bacteria, comprising of three enzymes: c-glutamyl kinase (G5K, EC 2.7.2.11), c-glutamyl phosphate
reductase (GPR, EC 1.2.1.41) and D1-pyrroline-5-carboxylate reductase (P5C, EC 1.5.1.2). Biosynthesis of threonine is predicted to start with
conversion of aspartate into L-aspartyl-4-phosphate by aspartokinase (EC 2.7.2.4) followed by aspartate-semialdehyde dehydrogenase (EC 1.
2.1.11), homoserine dehydrogenase (EC 1.1.1.3), homoserine kinase (EC 2.7.1.39) and threonine synthase (EC 4.2.3.1).
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and other higher eukaryotes in that G5K is part of a
bifunctional enzyme (D1–pyrroline-5-carboxylate syn-
thase, P5CS). Here, the kinase domain at the N-terminus
is fused with a glutamate-5-semi-aldehyde dehydroge-
nase (EC 1.2.1.41) domain at the C-terminus. As with
Leishmania the PUA domain is absent. It has been
shown that in both bacteria and plants that proline
biosynthesis is regulated by proline exerting feedback
inhibition of G5K or the equivalent kinase domain of
P5CS respectively [10].
Cloning, expression and purification of
recombinant LdG5K
The gene-encoding LdG5K (0.792 kb) was amplified
by PCR from L. donovani genomic DNA and cloned
into a modified pGEX expression vector. After purifi-
cation and on-column proteolytic cleavage of the GST
tag a single band was released (yield ~ 1 mgL1 of
culture) with a Mr of ~ 29 kDa by SDS/PAGE
(Fig. 4A). The theoretical Mr was calculated from the
amino acid sequence to be 29.033 kDa. Confirmation
was undertaken by tryptic analysis of the isolated pro-
tein determined by MALDI-TOF mass spectrometry
with 91% coverage and a mass of 29.10 kDa. The
molecular weight of the native LdG5K was determined
by size exclusion to be approximately 105 kDa consis-
tent with a tetrameric quaternary structure (Fig. 4B).
Biochemical characterisation and determination
of the kinetic parameters
Previous enzymatic activity assays have used fixed time-
point assays measuring product formation, either ADP
[23] or c-glutamyl phosphate converted into c-glutamyl
hydroxamate [24]. A spectrophotometric assay previ-
ously described for trypanothione synthetase activity
[25] was adapted to follow LdG5K activity with gluta-
mate, aspartate or other amino acid analogues. The
assay measured ADP formation by coupling the reac-
tion to pyruvate kinase/lactate dehydrogenase and mon-
itoring oxidation of NADH at 340 nm (Fig. 5A). The
kinase exhibited typical hyperbolic kinetics with respect
to L-glutamate and ATP (Fig. 5B,C) with kcat and Km
determined to be: 12.8  0.3 s1 and 10  0.7 mM;
11.7  0.3 s1 and 0.6  0.07 mM, respectively. Activa-
tion of G5K by Mg2+ shows high substrate inhibition
with kcat 11.6  0.8 s1, Ka 2.0  0.4 mM and Ki of
43  7 mM (Fig. 5D). These parameters are broadly
similar to those for bacterial glutamate kinases
(Table 1). Several analogues of ATP and L-glutamate
were tested as alternative substrates. GTP, CTP or UTP
did not replace ATP as phosphate donor as reported for
G5K from Thermotoga maritima [26]. Glutaric acid
showed 29% of the activity with glutamate as substrate,
whereas aminovaleric acid and 2-amino-4-phosphono-
butyric acid were inactive. No activity whatsoever could
be detected over a range of aspartate concentrations
(1–200 mM). L-citrulline and D,L-ornithine at 1 mM con-
centration did not inhibit the enzymatic conversion of
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Fig. 2. Phylogenetic relationship of G5K orthologues. The
phylogenetic tree was constructed as described in the Experimental
procedures. The full-length sequence data were obtained from
GenBank/EMBL databases under the following accession numbers:
AEE32297.1 for Arabidopsis thaliana P5CS1; XP_015621839.1 for
Oryza sativa P5CS; NP_001246877.1 for Drosophila melanogaster
P5CS; CAA64224.1 for Homo sapiens P5CS; P5CS; NP_062672.2
for Mus musculus P5CS; CAC35828.2 for Caenorhabditis elegans
P5CS; NP_216955.1 for Mycobacterium tuberculosis G5K;
AAC44174.1 for Corynebacterium glutamicum G5K; AAC22560.1 for
Haemophilus influenzae G5K; NP_414777.1 for Escherichia coli G5K;
CAB13740.1 for Bacillus subtilis G5K; WP_012108545.1 for
Campylobacter hominis G5K; EPY34138.1 for Strigomonas culicis
G5K; WP_011138443.1 for Wolinella succinogenes G5K; EFR48368.
1 Helicobacter canadensis G5K; AGT02536.1 for Herpetomonas
muscarum G5K; KPA74038.1 for Leptomonas pyrrhocoris G5K;
AGT02656.1 for Crithidia acanthocephali G5K; AIN99380.1 for
Leishmania panamensis G5K; AKK31239.1 for Leishmania mexicana
G5K; AKK31245.1 for Leishmania amazonensis G5K; AKK31242.1
for Leishmania donovani G5K; AKK31236.1 for Leishmania tropica
G5K; CAJ05678.1 for Leishmania major G5K. The trypanosomatid
clade is highlighted in blue.
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L-glutamate. These data indicate that the enzyme is a
G5K, with no functional activity as an aspartokinase.
Effect of proline on LdG5K activity and its
oligomeric state
In the absence of proline, the substrate glutamate
obeys hyperbolic kinetics (Fig. 5). However, the kinetic
behaviour with glutamate as variable substrate
becomes sigmoidal in the presence of increasing
concentrations of proline (Fig. 6A). Relative to the
kinetic parameters in the absence of proline, Hill slope
increases to a maximum of 3.0, S0.5 increases linearly,
whereas Vmax decreases with increasing proline concen-
trations (Fig. 6B). This behaviour is similar to that
reported for E. coli G5K [27]. The effect of excess pro-
line (10 mM) on the oligomeric state of LdG5K was
examined as studies undertaken for the E. coli enzyme
resulted in aggregation of tetramers into decamers [23].
This was not the case for LdG5K, with no change in
Leishmania ------------------------------------------------------------
Human           MLSQVYRCGFQPFNQHLLPWVKCTTVFRSHCIQPSVIRHVRSWSNIPFITVPLSRTHGKS 60
Ecoli           ------------------------------------------------------------
Leishmania      -MADILKSVKRIVVKVGSSILVDNQE--IAAHRIEALCQFIADLQTK-YEVILVTSGAVA 57
Human           AHRSELKHAKRIVVKLGSAVVTRGDECGLALGRLASIVEQVSVLQNQGREMMLVTSGAVA 120
Ecoli           -----MSDSQTLVVKLGTSVLTGGSR-RLNRAHIVELVRQCAQLHAAGHRIVIVTSGAIA 54
:.  : :***:*::::. ..   :   .:  :    : *:     :::*****:*
Leishmania      AGYTK----------------------KEMDKSYVPNKQALASMGQPLLMHMYYTELQKH 95
Human           FGKQRLRHEILLSQSVRQALHSGQNQLKEMAIP-VLEARACAAAGQSGLMALYEAMFTQY 239
Ecoli           AGREHLGY-------------------PELPAT-IASKQLLAAVGQSRLIQLWEQLFSIY 94
*  .                      *:  . : . .  *: **. *: ::   :  :
Leishmania      GILCAQMLLAAYDLDSRKRTINAHNTIEVLISHKVIPIINENDAT-----------ALDE 144
Human           SICAAQILVTNLDFHDEQKRRNLNGTLHELLRMNIVPIVNTNDAVVPPAEPNSDLQGVNV 299
Ecoli           GIHVGQMLLTRADMEDRERFLNARDTLRALLDNNIVPVINENDAV-----------ATAE 143
.*  .*:*::  *: . :.  * ..*:  *:  :::*::* ***.           .   
Leishmania      LVFGDNDRLSALVAHHFKADLLVILSDIDGYYTENPRTSTNATIRSVVHELSPDDLVAEA 204
Human           ISVKDNDSLAARLAVEMKTDLLIVLSDVEGLF-DSPPGSDDAKLIDIFY--PGDQQSVTF 356
Ecoli           IKVGDNDNLSALAAILAGADKLLLLTDQKGLYTADPRSNPQAELIKDVYGIDDALRAIAG 203
: . *** *:*  *    :* *::*:* .* :  .*  . :* : . .:           
Leishmania      TPNNRFATGGIVTKLQAAQFLLERGGKMYLSSGFHLEKAR----QFLLGGSHEIGTLFYS 260
Human           GTKSRVGMGGMEAKVKAALWALQGGTSVVIANGTHPKVSGHVITDIVEG--KKVGT-FFS 413
Ecoli           DSVSGLGTGGMSTKLQAADVACRAGIDTIIAAGSKPGVIG----DVMEG--ISVGTLFHA 257
. . .. **: :*::**      * .  :: * :         :.: *   .:** *.:
Leishmania      RVSS-------------------------------------------------------- 264
Human           EVKPAGP----------------------------------------------------- 420
Ecoli           QATPLENRKRWIFGAPPAGEITVDEGATAAILERGSSLLPKGIKSVTGNFSRGEVIRICN 317
...                                                    
Leishmania      --------------------------------------------------
Human           --------------------------------------------------
Ecoli           LEGRDIAHGVSRYNSDALRRIAGHHSQEIDAILGYEYGPVAVHRDDMITR 367
Fig. 3. Multiple alignment and key functional residues in G5K orthologues. The amino acid sequence of Leishmania donovani G5K was
compared to the human (excluding the C-terminal PC5S domain) and Escherichia coli homologues. The amino acid sequences were aligned
using MUSCLE (http://www.ebi.ac.uk/Tools/msa/muscle/). Identical amino acid residues are highlighted*. Conserved residues which interact
with the nucleotide (green), glutamate (red), interact with both (blue) and contain the PUA domain (yellow) are highlighted. Residues
involved in linking the two catalytic centres of each dimer (red boxes). Binding motifs for ATP (blue rectangle), conserved G5K domain
(green rectangle) and leucine zipper (peach rectangle) are also highlighted. Data from [23,31,80]. All highlighted residues are identical in
species causing mucocutaneous, cutaneous or visceral forms of leishmaniasis (L. donovani shows between 86 and 100% identity with
L. guyanensis, L. panamensis, L. braziliensis, L. mexicana, L. tropica, Leishmania major and Leishmania infantum).
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the oligomeric state being detected by size exclusion
(Fig. 6C). This supports the conclusion that higher
oligomerisation of E. coli G5K requires a PUA
domain and that allosteric kinetic behaviour is con-
ferred solely by the G5K domain [23].
Inhibition of LdG5K by proline analogues
A panel of L-proline analogues were surveyed for their
inhibitory activity against LdG5K at a fixed concen-
tration of 1 mM. Of these, D-proline was inactive while
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Fig. 4. Purification and physical properties of recombinant LdG5K. (A) SDS/PAGE analysis of purification scheme using GST-tagged LdG5K
with on-column cleavage resulting in the release of recombinant protein. Uni, uninduced sample; In, induced sample; F, flow through; W1
and W2, column wash 1 and 2; E, elution after on-column cleavage with Prescission Protease. Molecular weight standards (kDa) highlighted
on the left hand side of the gel. (B) Oligomeric structure of native LdG5K by size exclusion chromatography. Standard proteins and their
molecular weights (Da) are as follows: Thyroglobulin (bovine), 670 000; c globulin (bovine), 158 000; Ovalbumin (chicken), 44 000;
Myoglobin (horse), 17 000; Vitamin B12, 1350. LdG5K, glutamate 5-kinase.
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L-proline and three other compounds inhibited activity
by more than 30% (Table 2). L-proline was the most
effective with an IC50 value of 0.39  0.08 mM, fol-
lowed by 3,4-dehydro-L-proline, L-azetidine-2-carboxylic
acid and L-4-thiazolidine carboxylic acid. Methyla-
tion of either the a-carbon or the imino nitrogen or
esterification of the a-carboxylate abolished the inhi-
bitory activity of L-proline. Similarly expansion of
the pyrrolidine ring to a piperidine or various substi-
tutions on the pyrrolidine ring were not tolerated
(Table 2).
Genotypic analysis of WT and KO cells
To assess the possible role of G5K in the leishmania
life cycle, we sought to generate a proline auxotroph
by gene replacement. For a nonessential gene this is
normally straightforward requiring two rounds of gene
replacement with drug selectable markers to produce a
null mutant as shown in the schematic diagram
(Fig. 7A). In the case of an essential gene, gene dupli-
cation takes place, sometimes involving partial or com-
plete chromosomal duplication; alternatively, the gene
of interest is retained at the correct locus and the drug
selectable marker is inserted elsewhere in the genome.
Such genomic rearrangements are suggestive, but not
conclusive evidence that a gene is essential. Addition
of a ‘rescue copy’ of the gene of interest either
expressed on a plasmid or targeted to a different geno-
mic locus (e.g. ribosomal DNA locus) frequently
allows replacement of both chromosomal copies,
although this can also fail for technical reasons or the
locus being refractory to genetic manipulation [28].
It is important to note that, although leishmania are
aneuploid, the G5K-bearing chromosome 26 is diploid
in all species [29,30]. Restriction enzyme mapping
Table 1. Comparison of G5K kinetic parameters with other species.
Substrate/Metal ion Parameter Units Leishmania donovani
Escherichia colia
Thermotoga maritimabWT G5K domain
ATP K
app
m mM 0.6  0.07 1.6 1.6 3.3
kcat s
1 11.7  0.3 85.6 33.9 52
kcat/K
app
m M
1s1 19 500 53 600 21 200 15 800
Glutamate K
app
m mM 10  0.7 91 227 23
kcat s
1 12.8  0.3 109 48.8 51
kcat/K
app
m M
1s1 1280 1200 215 2200
Magnesium K
Mg
a mM 2.0  0.4 4.3 0.11 –
K
Mg
i mM 43  7 ~ 15 4.8 –
kcat s
1 11.6  0.8 77.2 21.7 –
The activity of LdG5K on varying concentrations of ATP, glutamate and free magnesium was determined by Pyruvate Kinase/Lactate Dehy-
drogenase coupling system. Free Mg was fitted to high substrate inhibition equation as described in the Experimental procedures. Data cal-
culated from aPerez-Arellano et al. [81] for the full-length protein (WT) and for the protein lacking the PUA domain (G5K domain) and bPerez-
Arellano and Cervera [26].
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Table 2. Inhibition of recombinant LdG5K by proline analogues compared with Escherichia coli G5K. IC50 values where measured if LdG5K activity
was < 70% in the presence of 1 mM proline analogue. The IC50 values were measured as described in the Experimental procedures by measuring
the enzyme velocity as a function of inhibitor concentration and the data were fitted using a four-parameter IC50 equation. NT, not tested.
Proline analogue LdG5K activity (%) with 1 mM LdG5K IC50 (mM) EcG5K IC50 (mM)
a
L-proline
NH
OH
O 4 0.39  0.08 0.15
D-proline
NH
OH
O 103 – NT
3,4-dehydro-D,L-proline
NH
OH
O 9 0.49  0.02 0.16
L-azetidine-2-carboxylic acid
NH
OH
O 25 0.73  0.07 1.38
L-4-thioproline
NH
S
OH
O 66 1.8  0.2 1.0
L-pipecolinic acid
NH
OH
O 100 – NT
D-pipecolinic acid
NH
OH
O 100 – NT
N-methyl-L-proline
N
OH
O 100 – NT
L-proline methyl ester H
N
O
O 100 – 3.5
a-methyl-L-proline
NH
OH
O 82 – 4.7
Cis-3-hydroxy-L-proline
NH
OH
OHO 100 – NT
Cis-4-hydroxy-L-proline
NH
HO
OH
O 87 – 1.22
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confirmed that G5K is present as a single copy per
haploid genome in the LdBOB strain used here. Single
drug-resistant lines (SDR) were obtained by transfec-
tion with the PAC gene replacement construct fol-
lowed by selection for puromycin resistance in either
WT leishmania or in WT cells previously transfected
with the overexpression rescue cassette for G5K
(RCWT). Resistant lines were obtained bearing the cor-
rect replacement of one G5K allele to produce a SDR
and RCSDR clonal line (Fig. 7B). Attempts to delete
the second allele by transfection with the HYG con-
struct in the SDR clone to produce a double knockout
lacking G5K were unsuccessful (Fig. 7C). Although
Southern blot analysis confirmed that PAC and HYG
had been correctly integrated at the G5K locus
(Fig. 7D,E), a copy of the endogenous G5K was also
retained at the correct genomic locus (Fig. 7C). Trans-
fection of the clone bearing the ectopic rescue con-
struct (RCDDR) with HYG also failed to generate a
chromosomal null mutant (Fig. 7C). The detection of
two higher bands (5–4 kbp range) with the HYG mar-
ker as well as a doublet band potentially representing
the correct size 1.6 and 1.3 kb fragments indicates cor-
rect insertion at the G5K locus and elsewhere in the
genome (Fig. 7E). There was little difference in growth
rates for WT, DDR and the equivalent rescue clonal
lines with doubling times of 8.41  0.07; 8.54  0.05;
9.09  0.03 and 9.85  0.01 h respectively. To
establish that the overexpressing lines were produc-
ing functional protein that would act as a rescue
when both allelic copies were deleted, extracts of WT
and RCWT lines were assayed for G5K activity. In the
RCWT extract a net G5K activity of
34.7  0.9 nmolmin1mg1 was obtained against
a background ATPase activity of 12.9  1.8
nmolmin1mg1. No net G5K activity could be
detected for the WT extract due to the high back-
ground ATPase activity. However, addition of recom-
binant LdG5K to the WT extracts was readily
measurable indicating that the extracts did not contain
Table 2. (Continued).
Proline analogue LdG5K activity (%) with 1 mM LdG5K IC50 (mM) EcG5K IC50 (mM)
a
Trans-4-hydroxy-L-proline
NH
HO
OH
O 89 – 22.6
N-acetyl-L-proline
N
OH
O
O
93 – > 100
L-trans-pyrrolidine-2,4-dicarboxylic acid
O
OH
H
N
O
HO
84 – NT
L-prolinamide
NH
NH2
O 96 – NT
Trans-1-acetyl-4-hydroxy-L-proline
N
OH
O
O
HO
100 – NT
aData from Perez-Arellano et al. [23].
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an inhibitor of the reaction. Thus, the failure to create
a chromosomal null mutant cannot be ascribed to fail-
ure of G5K expression, but could be due to other
technical reasons. Together, the results obtained here
are suggestive, but not conclusive that G5K is essential
for growth and survival of the parasite.
Discussion
This study provides definitive evidence that the protein
encoded by LdBPK_262740.1 is a bone fide G5K (EC
2.7.2.11) and not an aspartate kinase (EC 2.7.2.4). The
kinetic parameters are broadly equivalent to the few
prokaryotic G5Ks that have been studied in any detail
(Table 1). Catalytic processes for microbial G5K’s and
plant P5CS enzymes are regulated through proline
feedback inhibition. Proline, the end product of the
pathway, induces the parasite enzyme to switch from
hyperbolic to sigmoidal behaviour with respect to glu-
tamate, with changes in the S0.5 for glutamate, Hill
coefficient and kcat similar to those reported for E. coli
G5K [27]. However, unlike the E. coli enzyme [23] the
tetrameric structure of LdG5K is not affected by pro-
line possibly due to the lack of a PUA domain. In
E. coli G5K the addition of proline shifts the oligo-
meric state from tetramer (a dimer of dimers in crys-
tallographic studies [31]) to a possible dodecamer
(trimer of tetramers) at infinite proline concentration
[23]. Deletion of the PUA domain (absent in LdG5K)
abolishes this aggregation, but not the feedback inhibi-
tion by proline. Molecular modelling and site-directed
mutagenesis studies on the E. coli and
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Fig. 7. Assessing the essentiality of G5K. (A) Schematic representation of the gene replacement strategy and possible outcomes. The light
blue bars represent the 50- and 30- UTRs flanking the G5K locus used for gene replacement by homologous recombination. A map of the
rescue construct pIR1SAT_LdG5K is included showing the Swa I restriction sites used to linearise the construct targeted for insertion into
the (ectopic) ribosomal DNA locus. (B–E) Genotypic analysis of transgenic clones for WT, SDR, DDR and their corresponding rescue
constructs (RCWT, RCSDR and RCDDR). gDNA samples were digested with Sac II and Southern blots prepared as described in Experimental
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hygromycin phosphotransferase (E). Coloured arrows indicate that gene replacement had occurred at the G5K chromosomal locus.
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Campylobacter jejuni G5Ks predict a proline-binding
pocket adjacent to the substrate binding site involving
Asn34 and Asp 137 [23], residues that are conserved in
LdG5K (Fig. 3). The structure-activity relationship of
proline analogues determined here agree well with, and
extend, the previous study [23] and emphasise the
specificity of this binding pocket. Based on the esti-
mated intracellular concentrations of glutamate
(14 mM) and proline (3 mM) of promastigotes grown
in amino acid replete medium [32], our studies predict
that the enzyme will be essentially inactive under these
nutrient-rich conditions (Fig. 6A). Thus, the regulatory
parameters determined here appear to be physiologi-
cally relevant to the intact cell, supporting the observa-
tion that biosynthesis only occurs under conditions of
amino acid starvation [14]. Unlike the long isoform of
mammalian P5CS [33], which is involved in arginine
biosynthesis, citrulline and ornithine do not inhibit
LdG5K. This is consistent with the fact that leishma-
nia are auxotrophic for arginine when cultured in the
presence of glucose [32] and lack genes for two key
pathway enzymes linking proline biosynthesis with
ornithine / arginine metabolism (ornithine aminotrans-
ferase and ornithine deiminase).
Metabolism of proline in leishmania has similarities
and differences with its trypanosomatid cousins, the
African trypanosome, Trypanosoma brucei and the
South American trypanosome, Trypanosoma cruzi.
While all three species are capable of using proline as
an energy source, converting proline into glutamate
and subsequently into tricarboxylic acid intermediates
[6,18,34,35], metabolic labelling studies show that only
leishmania is capable of synthesising proline de novo
from either glutamate or glucose [14,18,34,36]. There is
an absolute requirement for proline to support growth
of T. brucei procyclic forms [18], whereas this is not
the case for several Leishmania spp. [32]. Given the
lack of bioinformatic or biochemical evidence for alter-
native routes for proline biosynthesis from ornithine
(via ornithine d-aminotransferase or ornithine
cyclodeaminase) [37] this suggests that the G5K path-
way is necessary and sufficient for growth of pro-
mastigotes in media lacking proline.
In addition to proline’s role as a protein building
block, as a major energy source and as a source of
nitrogen, this imino acid has been implicated in
response to various forms of cellular stress. Intracellu-
lar accumulation of proline is a common phenomenon
in response to environmental stress in bacteria, proto-
zoa, algae, plant and marine invertebrates (for a
review see [36,38]). In other organisms proline has
been shown to function as an osmoprotectant, as a
small molecule chaperone preventing protein
aggregation, as a metal chelator and as a scavenger of
reactive oxygen species (ROS), specifically the hydro-
xyl radical and singlet oxygen [38]. Proline is also pro-
posed to help maintain the GSH thiol redox balance
by scavenging ROS and by stabilising key antioxidant
enzymes.
These possible roles for proline have not been exten-
sively studied in the trypanosomatids. Proline, along
with glutamate and alanine, have been implicated in
responses to osmotic stress [39,40] and this may be of
biological relevance to these parasites’ survival in the
insect gut. In T. cruzi proline is reported to modulate
resistance to ROS and resistance to trypanocidal drugs
through a novel D,L-proline transporter [41]. T. cruzi
also possesses an intracellular proline racemase and a
secreted proline racemase that acts as B-cell mitogen
modulating the immune response [42]. However, the
leishmania genome does not contain a proline
racemase.
One specific role for proline in leishmania is in
response to purine starvation [43]. Leishmania are pur-
ine auxotrophs and lack the ability to synthesise puri-
nes de novo. Thus, they are entirely dependent on an
exogenous supply from the extracellular medium. Pur-
ine starvation not only markedly upregulates purine
transporters and purine salvage enzymes but also
upregulates proline biosynthetic pathway and down-
regulates proline degradation, resulting in a 6- to 10-
fold increase in intracellular proline concentration [43].
The role of proline in this stress response is not under-
stood, but could act to augment the increased levels of
proteins involved in protein folding/protein stability,
as well as key trypanothione-dependent antioxidant
enzymes observed [43].
One key question is why do Leishmania spp. have
this de novo biosynthetic pathway, whereas T. brucei
and T. cruzi do not? One possibility concerns the dif-
ferent parasite locations in their mammalian hosts.
T. brucei resides extracellularly in the blood, lymph
and interstitial fluid, whereas T. cruzi resides intracel-
lularly in the cytosol of many different cell types in
many different tissues. Thus, both of these organisms
should have ready access to proline and therefore have
no requirement for de novo biosynthesis. In contrast,
leishmania parasites reside within an acidic phagolyso-
somal compartment in macrophages – the para-
sitophorous vacuole (PV). Information on the
availability of nutrients in the PV is lacking and can
only be inferred from the nutritional requirements of
the parasites. Thus, purines, haem, vitamins, iron and
essential amino acids must be available in the PV in
sufficient amounts to sustain growth [44]. Studies with
Salmonella auxotrophs suggest that the macrophage
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acidic compartment in which they reside is nutrient
poor for purine, pyrimidine, aromatic amino acids, his-
tidine and proline [45–47]. Notably, Salmonella enter-
ica lacking G5K (ProB) are defective for survival
in vitro in macrophages and in vivo in mice [46]. A
related study in Mycobacterium tuberculosis showed
that a proline auxotroph (proC, D1-pyrolline 5-carbox-
ylate reductase) displays attenuated virulence both in
bone marrow-derived macrophages and in mice [48].
While both of these studies indicate that proline is lim-
iting in these specialised macrophage phagolysosomal
compartments, it may not apply to the leishmania PV,
which is known to be in contact with the external
medium via endocytosis [49].
To assess the possible role of G5K in the leishmania
life cycle, we sought to generate a proline auxotroph
by gene replacement. Despite the presence of proline
in the medium that should serve as a nutritional res-
cue, it was not possible to create a G5K null mutant.
Instead, both drug selection markers were correctly
inserted at the G5K locus, with retention of an addi-
tional copy of G5K. This result is suggestive, but not
conclusive, that G5K is essential. Additional evidence
of essentiality can be obtained using a genetic rescue
strategy that should allow direct gene replacement
without additional chromosomal alterations. In our
case, multiple attempts to create a chromosomal G5K
null with an episomal rescue construct in the riboso-
mal locus were unsuccessful even in the presence of
proline (0.35 mM) in the growth medium. Further
work is required to assess whether G5K has an addi-
tional structural or enzymatic function that remains to
be elucidated.
A second possible unique function relates to a class of
drugs used to treat leishmaniasis, namely, the pentava-
lent antimonials, sodium stibogluconate (pentostam)
and meglumine antimonate (glucantime). These metal-
loid-sugar complexes are thought to be activated by
reduction of SbV to the trivalent (SbIII) form in the host
macrophage, the intracellular amastigote or possibly
both [3]. The mode of action of SbIII is not fully under-
stood, but is likely to include inhibition of key dithiol
antioxidant proteins such as trypanothione reductase
and tryparedoxin peroxidase with perturbation of thiol-
redox homeostasis and thiol-buffering capacity [50–53].
Resistance to antimonial compounds in Bihar State,
India is now so widespread that antimonials are no
longer recommended as front-line treatment. One the-
ory why this has occurred in India, but not in other geo-
graphic regions, relates to the metalloid, arsenic. The
hypothesis is that the human population living in parts
of Bihar are exposed to high levels of arsenic in drinking
water and, in infected patients, arsenic selects for
parasite resistance to trivalent arsenic and concomitant
resistance to antimonials [54]. Evidence to support this
theory has been obtained in vitro [55,56] and in animal
models [57], although a retrospective clinical epidemio-
logical study proved to be insufficiently powered to pro-
vide a definitive answer to this question [58]. It is
noteworthy that arsenic-contaminated soil has a harm-
ful effect on plant growth through perturbation of
numerous metabolic pathways and other biological
functions [59] and antimony-contaminated soil induces
similar adverse effects on growth [60]. Strikingly, plants
exposed to either inorganic arsenic or antimony respond
by increasing their intracellular proline content [61–63].
In leishmania, no changes in expression of G5K, gluta-
mate-5-semi-aldehyde dehydrogenase or pyrroline-5-
carboxylate reductase have been noted in whole-genome
sequencing, proteomics or gene expression studies
comparing drug-sensitive and drug-resistant parasites
[64–68]. However, a metabolomic study noted elevated
glutamate and proline in antimony-resistant cells com-
pared with susceptible Leishmania infantum promastig-
otes [69]. The mechanism by which glutamate or proline
convey resistance is not understood: both amino acids
are precursors for the antioxidant metabolites glu-
tathione and trypanothione and proline could act as a
scavenger of ROS induced by SbIII [70]. Whether these
changes in amino acid content occur in antimony-resis-
tant clinical isolates has not been studied.
In conclusion, this study confirms the key putative
enzyme in proline biosynthesis is indeed a classical
G5K. G5K lacks aspartokinase activity leaving the
question of how parasites synthesise threonine unan-
swered. Further work is required to establish the func-
tional roles of proline in this parasite. In particular, is
G5K a potential drug target in the intracellular
amastigote stage of the life cycle?
Experimental procedures
Chemicals and reagents
Chemicals and reagents used in this study were all of the
highest purity which are commercially available. All sub-
strates, cofactors and enzymes were products from Sigma
Aldrich (Gillingham, UK).
Leishmania donovani promastigote cell culture
maintenance
Leishmania donovani LdBOB promastigotes (derived from
MHOM/SD/62/1S-CL2D) were routinely passaged in mod-
ified M199 medium with 10% fetal calf serum as previously
described [71].
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Cloning and generation of transgenic cell lines
All constructs made were prepared and sequenced for elec-
troporation using QIAprep Miniprep Plasmid Kit (Qiagen,
Venlo, the Netherlands). Primers used in this study to gen-
erate the overexpression and knockout constructs (Table 3)
are based on the GeneDB sequences for L. infantum G5K
(LinJ.26.2740).
For the gene replacement cassettes, the 50 and 30 UTRs
directly adjacent to the ORF were amplified using 50UTR-
NotI forward, 50UTR-HindIII/PmeI reverse and 30UTR-
Pme I/BamHI forward, 30UTR-NotI reverse respectively.
Using the following conditions: 95 °C for 1 min; 55 °C for
2.5 min; 72 °C for 3 min for 30 cycles, PCR products were
used together in a further overlapping extension PCR to
yield a product containing the 50-UTR linked to the 30-
UTR via a short HindIII – BamHI linker region with a
NotI site at each end. (Table 3). This product was subse-
quently ligated into the NotI site of pGEM-5Zf(+) vector
(Promega, Southampton, UK). The selectable drug resis-
tance genes puromycin N-acetyl transferase (PAC) and
hygromycin phosphotransferase (HYG) were introduced
into this vector via the HindIII and BamHI within the lin-
ker region cloning sites and sequenced.
To generate a recovery construct expressing LdG5K, pIR1-
SAT_LdG5K, the G5K ORF was amplified from L. donovani
genomic DNA using oeG5K forward and reverse primers
(Table 3) and subsequently cloned into the integrating stable
expression vector pIR1SAT [72]. For recombinant expression
in E. coli, LdG5K was amplified from the pIR1SAT_LdG5K
construct, with G5K forward and reverse primers (Table 3),
subsequently cloned into a modified pGEX-6P-1 vector
(Amersham Biosciences, Buckinghamshire, UK) containing
in-frame N-terminal His-GST tag, using the BamHI and the
EcoRI restriction sites. All the constructs generated were veri-
fied by DNA sequencing (http://www.dnaseq.co.uk).
Generation of L. donovani promastigote G5K
knockout and overexpresser cells
DNA constructs were prepared for electroporation into
LdBOB promastigotes and cloned with all procedures per-
formed as previously described [73]. Briefly, parasites were
electroporated using Human T-cell Nucleofactor with pro-
gramme V-033. Post-transfection, cells were allowed to rest
for 16–24 h prior to appropriate selection for PAC
(20 lgmL1 puromycin) or HYG (50 lgmL1 hygromy-
cin). Cloned cell lines were generated by limiting dilution
and maintained in the presence of selective drugs. To gen-
erate WT and SDR lines overexpressing LdG5K, the pIR1-
SAT_LdG5K recovery construct was linearised by digestion
with SwaI and electroporated into cells with selection for
expression of streptothricin acetyltransferase (SAT) with
100 lg nourseothricinmL1.
Genotypic analysis
DNA was prepared for Southern blot analysis from WT
and KO cells. WT DNA (5 lg) was digested various
restriction and resolved on a 0.8% agarose gel. The DNA
was subsequently transferred onto nitrocellulose and UV
cross-linked. The blots were hybridised with probes specific
for G5K ORF and 50 UTR. The probes were labelled with
fluorescein–dUTP by DIG labelling kit (Roche, Welwyn
Garden City, UK) and the blots processed as previously
described [74].
Recombinant expression and purification of
LdG5K
Recombinant pHis-GST:LdG5K was expressed in
E. coli strain C41(DE3) pLysS. Transformed cells were cul-
tured in auto-induction medium (LB medium supplemented
with 0.5 gL1 glucose and 2 gL1 a-lactose) plus
100 lgmL1 ampicillin at 37 °C with shaking at 200 r.p.m.
for 2 h and the temperature was reduced to 18 °C over-
night. Uninduced cells were grown in medium lacking glu-
cose and a-lactose. Soluble protein was purified from
clarified lysate on glutathione (GST) resin. Briefly, cells
were harvested by resuspending in lysis buffer [PBS/0.25 M
NaCl/5% (v/v) glycerol] supplemented with EDTA-free
complete protease inhibitor cocktail (Roche) and lysed
using a continuous cell disruptor (Constant Systems,
Daventry, UK) at 30 000 psi. Clarified lysates (centrifuged
at 45 000 g for 45 min, 4 °C) were applied to GST resin
Table 3. Primers used for knockdown, knockout and rescue constructs. Upper case letters refer to gene sequences and enzyme restriction
sites are underlined.
Primer name Sequence
ORF-BamHI forward 50-ggatccaATGGCGGACATCTTGAAG-30
ORF-BamHI reverse 50-ggatccTCAAGATGAAACTCTCGA-30
50UTR-NotI forward 50-ataagaatgcggccgcCGCTAATGATTACACTAC-30
50UTR-HindIII/PmeI reverse 50-gtttaaacttacggaccgtcaagcttGCTTGATTCCGCGTGGAC-30
30UTR-PmeI/BamHI forward 50-gacggtccgtaagtttaaacggatccAGCGCTTAGGGATGTCAC-30
30UTR-NotI reverse 50-ataagtaagcggccgcGTTCGATACCGTTTTGAGA-30
G5K-BamHI forward 50-gcgcggatccATGGCGGACATCTTGAAGT-30
G5K-EcoRI forward 50-gcgcgaattcTCAAGATGAAACTCTCGAAT-30
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(GE Healthcare, Little Chalfont, UK), pre-equilibrated in
lysis buffer. The lysate was batch bound at 4 °C for 2 h
with subsequent washing prior to on-column cleavage by
PreScission protease for 24 h according to manufacturer’s
instructions. Protein fractions were analysed by SDS/PAGE
using a NuPAGE Novex 4–12% Bis-Tris gel (Life Tech-
nologies, Paisley, UK) and visualised for purity by Coo-
massie Brilliant Blue staining. Prepared enzyme was buffer
exchanged and concentrated using 3 MWCO filtration unit
(Vivaspin 20; Millipore, Watford, UK) and stored in
50 mM HEPES pH 7.5 containing 20% (v/v) glycerol and
0.0005% (w/v) Na azide as snap-frozen aliquots at 80 °C.
The sequence and identity of the purified protein was veri-
fied by tryptic mass fingerprinting with 79% sequence cov-
erage (Proteomic and Mass Spectrometry facility,
University of Dundee). Proteins were analysed by SDS/
PAGE using 4–15% Bis-Tris NuPAGE polyacrylamide gels
(Invitrogen, Life Sciences, Paisley, UK) and 19 MES run-
ning buffer according to manufacturer’s instructions. Pro-
tein concentration was measured spectrophotometrically at
595 nm using the Bradford reagent (Bio-Rad, Watford,
UK) and BSA as a standard [75].
Analytical gel filtration
The native confirmation of LdG5K was confirmed by size
exclusion chromatography using a Superdex 200 H/R 10/30
column fitted onto an AKTA FPLC system (both from GE
Healthcare) with a buffer comprising 50 mM Tris-HCl, pH
7.2 and 0.15 M NaCl running at 0.5 mLmin1 at room
temperature. Gel filtration protein standards (Bio-Rad)
used were as follows: vitamin B12 (1350 Da); horse myo-
globin (17 000 Da); chicken ovalbumin (44 000 Da); bovine
c-globulin (158 000 Da) and bovine thyroglobulin
(670 000 Da). The void volume was 8.3 mL. The equa-
tion for estimating the molecular mass was derived from
plots of Ve/Vo against log MW of the standards.
Kinetic characterisation of recombinant LdG5K
and clarified L. donovani lysates
A continuous spectrophotometric enzyme assay was devel-
oped to follow the conversion of ATP into ADP using a
coupled enzyme system utilising pyruvate kinase (PK) and
lactate dehydrogenase (LDH; Fig. 4). Both coupling
enzymes were present in excess and G5K activity was mea-
sured by the consumption of NADH at 340 nm. Standard
assay conditions contained the following in a 1 mL reac-
tion mix: 0.1 M imidazole, pH 7.4; 1 mM DTT; 5 mM ATP;
5 mM MgCl2; 0.1 mgmL1 BSA; 50 U PK/LDH; 1 mM
phosphoenolpyruvate; 250 mM NADH; 0.75 lg LdG5K
and the reaction was initiated with 100 mM Na glutamate.
The assay components were pre-equilibrated at 25 °C for
5 min prior to initiation with the substrate. When ATP was
varied, 150 mM Na glutamate and 5 mM MgCl2 were kept
in excess of ATP. When glutamate was varied 5 mM ATP
and 5 mM MgCl2 were kept constant. Activity was calcu-
lated from the initial linear rate with the extinction coeffi-
cient of NADH, 6220 M1cm1 [76]. All data were
analysed by nonlinear regression using GraFit and fitted to
the Michaelis–Menten equation, except for determining the
free Mg concentration requirement which was fitted to a
high substrate inhibition equation:
m ¼ Vmax
1þ KmS þ SKs
i
In the presence of proline the enzyme displayed sig-
moidal kinetics with respect to glutamate and data were fit-
ted by nonlinear regression to the Hill equation describing
allosteric behaviour:
m ¼ Vmax½S
n
Kn þ ½Sn ;
where n = Hill coefficient.
Log-phase cultures of L. donovani WT and WT-overex-
pressing G5K (1 9 107 cellsmL1) were harvested by cen-
trifugation (800 g, 10 min, 4 °C) and washed twice with
ice-cold PBS containing cOmpleteTM, EDTA-free protease
inhibitor cocktail (Roche, Basel, Switzerland). Clarified
lysates were prepared as previously described [74]. Briefly,
cells were osmotically lysed with ice-cold distilled water
(containing cOmpleteTM, EDTA-free protease inhibitors),
frozen and thawed three times in liquid nitrogen (a biosaf-
ety procedure) and finally resuspended in an equal volume
of 29 assay buffer (0.2 M imidazole, pH7.4; 2 mM DTT).
The lysates were buffer exchanged into 19 assay buffer to
remove cofactors and substrates prior to determining
protein content.
Inhibitors
Initially single-point assays of a set of proline analogues
were tested at 1 mM concentration using the coupled assay
described above. Any analogue which resulted in > 70%
inhibition in LdG5K activity was retested under varying
concentrations to determine their IC50 value. All measure-
ments were done in triplicate.
Phylogenetic analysis
The phylogenetic tree was constructed from a highly con-
served region of deduced G5K and P5CS amino acid
sequences. The evolutionary history was inferred using the
Neighbour-Joining method [77]. The optimal tree with the
sum of branch length = 7.43079248 is shown. The tree is
drawn to scale, with branch lengths in the same units as
those of the evolutionary distances used to infer the phylo-
genetic tree. The evolutionary distances were computed
using the Poisson correction method [78] and are in the
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units of the number of amino acid substitutions per site.
The analysis involved 24 amino acid sequences. All posi-
tions containing gaps and missing data were eliminated.
There were a total of 203 positions in the final dataset.
Evolutionary analyses were conducted in MEGA7 [79].
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